Recently, it has been demonstrated that PLCL1 induces abnormal lipid metabolism in tumour cells by interacting with metabolism-related gene uncoupling protein 1 (UCP1), repressing RCC progression [8]. This evidence concerns the gene PLCL1 and neoplasm.